Breast Cancer News and Research

Latest Breast Cancer News and Research

Sunshine Biopharma to present new Adva-27a data against cancer at AACR meeting

Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that they will be presenting scientific data at the American Association for Cancer Research Meeting April 2-6, 2011 in Orlando Florida.

2 Apr 2011

New research identifies diverse barriers to breast cancer screening and treatment

A landmark breast health care publication reveals a multitude of barriers that keep women of developing nations from being screened and treated for breast cancer - but offers tools to help countries improve their breast care programs.

2 Apr 2011

Three abstracts from SuperGen PIM kinase inhibitor program to be presented at AACR

SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of three abstracts from the SuperGen PIM kinase inhibitor program. Poster presentations by SuperGen and collaborators will occur on April 3 and 5, 2011 at the American Association for Cancer Research 102nd Annual Meeting in Orlando, Florida.

2 Apr 2011

LCA calls for comprehensive plan of action to reduce lung cancer mortality

Lung Cancer Alliance called again today for a comprehensive plan of action that will make reducing lung cancer mortality a public health priority.

2 Apr 2011

University of Houston part of multi-investigator $5.2M CPRIT award for prostate cancer research

A pair of University of Houston (UH) researchers and their colleagues will begin work to develop new methods for treating the most severe form of prostate cancer thanks to $5.2 million in grants recently awarded by the Cancer Prevention and Research Institute of Texas (CPRIT).

2 Apr 2011

Lilly's Axiron testosterone replacement therapy now available in US pharmacies

Eli Lilly and Company announced today that Axiron® (testosterone) topical solution is available in pharmacies throughout the United States. Axiron is a prescription medicine used to treat adult males that have low or no testosterone. Safety and efficacy of Axiron in males younger than 18 years of age have not been established.

1 Apr 2011

Biocept, academic collaborators' posters on CTCs to be presented at AACR meeting

Biocept, Inc. today reported that its scientists and academic collaborators will present four posters at the 102nd Annual Meeting of the American Association for Cancer Research taking place in Orlando, Florida April 2-6, 2011.

1 Apr 2011

New lifesaving technology can combat cancer

Imagine the benefits if there was technology that pinpointed exactly which chemotherapy drugs work best in fighting each individual's type of cancer. No more guessing. No more trial and error. The good news is that such lifesaving technology is on its way to becoming reality.

1 Apr 2011

KeyBank Foundation awards $1M grant for providing breast cancer education to medically underserved women

A $1 million grant from KeyBank Foundation to Susan G. Komen for the Cure® will fund a training and outreach program potentially reaching more than 100,000 medically underserved women in selected communities that KeyBank serves. The grant, announced today by Susan G. Komen for the Cure and KeyCorp, is the Foundation's largest-ever grant at the national level and will be used to establish the Susan G. Komen Lay Health Advisors Training Program.

1 Apr 2011

New study examines psychological, social challenges of women with breast cancer

When an aggressive form of breast cancer strikes a young woman, what kind of stress, anxiety and other psychological and social challenges does she face?

1 Apr 2011

Syndax to present entinostat data against cancer at AACR meeting

Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced 11 posters on entinostat, an oral, highly selective, class I histone deacetylase inhibitor, will be presented at the 102nd Annual American Association for Cancer Research meeting April 2 to April 6 in Orlando, FL.

1 Apr 2011

Mitomics introduces new test to detect prostate cancer

Mitomics, world leader in the research and development of mitochondrial genome-based products to improve clinical insight and therapeutic decisions, announced today the launch of its flagship product, the Prostate Core Mitomic Test, a revolutionary new test that uses the science of mitochondrial DNA to accurately determine the absence or presence of cancerous cells using previously obtained prostate biopsy tissue.

1 Apr 2011

Alnylam completes patient enrollment in ALN-VSP Phase I trial against liver cancer

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it has completed enrollment in its ALN-VSP Phase I multi-center, multinational, open label, dose escalation clinical trial.

1 Apr 2011

RXi Pharmaceuticals to acquire Apthera

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, and Apthera, Inc., a private biotechnology company developing a pipeline of peptide-based immunotherapies for the adjuvant treatment of HER2-positive breast and other cancers, announced today the signing of a definitive merger agreement under which RXi will acquire Apthera.

31 Mar 2011

Experts discuss about need for national colorectal cancer screening program at Capitol Hill

On Capitol Hill today, colorectal cancer experts and advocates will gather to promote the establishment of a national colorectal cancer screening program in an effort to save lives.

From Evident Corporation - Life Sciences 31 Mar 2011

Researchers identify drug candidate that can treat prostate cancer

The best way to prevent the lethal spread of prostate cancer is by stopping cancer cell invasion of other tissues. Available treatments such as chemotherapy are toxic and can often be risky for older men, who are also most likely to get prostate cancer.

31 Mar 2011

BioSante completes patient enrollment in LibiGel Phase III trial against HSDD

BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the second of two pivotal Phase III LibiGel safety and efficacy trials has been completed. Enrollment in the first LibiGel efficacy trial was completed in February.

30 Mar 2011

Women can benefit from Ontario's breast cancer screening program

The Ontario Budget has taken a step toward providing the type of expanded screening for breast cancer that Ontario women need, the Canadian Breast Cancer Foundation —Ontario Region says.

30 Mar 2011

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

Silence Therapeutics plc a leading global RNA interference therapeutics company, announces that interim data from its ongoing Phase I clinical study of Atu027, the Company's lead internal therapeutic candidate, have been accepted for poster presentation at the 2011 American Society of Clinical Oncology Annual Meeting.

30 Mar 2011

Canadian Cancer Society applauds Ontario government for allocating new funding for Breast Screening Program

The Canadian Cancer Society is pleased women with a family history of breast cancer and other higher-risk women will now have access to high-quality breast screening through the Ontario Breast Screening Program.

30 Mar 2011

Breast Cancer News and Research

Latest Breast Cancer News and Research

Sunshine Biopharma to present new Adva-27a data against cancer at AACR meeting

New research identifies diverse barriers to breast cancer screening and treatment

Three abstracts from SuperGen PIM kinase inhibitor program to be presented at AACR

LCA calls for comprehensive plan of action to reduce lung cancer mortality

University of Houston part of multi-investigator $5.2M CPRIT award for prostate cancer research

Lilly's Axiron testosterone replacement therapy now available in US pharmacies

Biocept, academic collaborators' posters on CTCs to be presented at AACR meeting

New lifesaving technology can combat cancer

KeyBank Foundation awards $1M grant for providing breast cancer education to medically underserved women

New study examines psychological, social challenges of women with breast cancer

Syndax to present entinostat data against cancer at AACR meeting

Mitomics introduces new test to detect prostate cancer

Alnylam completes patient enrollment in ALN-VSP Phase I trial against liver cancer

RXi Pharmaceuticals to acquire Apthera

Experts discuss about need for national colorectal cancer screening program at Capitol Hill

Researchers identify drug candidate that can treat prostate cancer

BioSante completes patient enrollment in LibiGel Phase III trial against HSDD

Women can benefit from Ontario's breast cancer screening program

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

Canadian Cancer Society applauds Ontario government for allocating new funding for Breast Screening Program

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in